Trial intelligence / Profile preview

Perioperative intravenous lignocaine for chronic pelvic pain during operative gynaecological laparoscopy

ACTRN12621000589886Phase 2Recruiting

Sponsor
Monash Health
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in chronic prostatitis (CP) comparing Perioperative intravenous lignocaine with Placebo control intravenous saline (2 arms). Primary endpoint: Visual Analogue Scale pain scores. Started Jun 2021; status: recruiting.

02

Drugs

lidocaine
03

Conditions

chronic prostatitis (CP)

Beyond the preview

Go deeper on ACTRN12621000589886.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12621000589886.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call